CNL’S CNRI-H Program Continues Strong Growth Thanks to New Projects With Repare Therapeutics and Defence Therapeutics [Canadian Business Journal (Canada)]
Repare Therapeutics Inc. - Common Shares (RPTX)
Company Research
Source: Canadian Business Journal
Canada’s national nuclear laboratories announces new projects with leading Canadian biopharmaceutical companies through collaborative research programCHALK RIVER, Ontario, Jan. 20, 2025 (GLOBE NEWSWIRE) — Canadian Nuclear Laboratories (CNL), Canada’s premier nuclear science and technology organization, is pleased to announce that it is collaborating with two leading Canadian healthcare biotech companies – Repare Therapeutics and Defence Therapeutics – on individual research projects through its Canadian Nuclear Research Initiative – Health (CNRI-H) program. Launched in 2021, the CNRI-H program is designed to accelerate the development of targeted radiopharmaceuticals in Canada through joint research projects related to oncology, targeted alpha therapy, radiopharmaceuticals and medical isotope development.Repare and CNL plan to leverage the strengths of both organizations which cut across radiobiology, preclinical evaluation, and the discovery of therapeutics that kill cancer cells by
Show less
Read more
Impact Snapshot
Event Time:
RPTX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
RPTX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
RPTX alerts
High impacting Repare Therapeutics Inc. - Common Shares news events
Weekly update
A roundup of the hottest topics
RPTX
News
- BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Repare Therapeutics Inc. (Nasdaq – RPTX), Axalta Coating Systems Ltd. (NYSE – AXTA), Blue Foundry Bancorp (Nasdaq – BLFY), Golden Entertainment, Inc (Nasdaq - GDEN)GlobeNewswire
- Halper Sadeh LLC Encourages RPTX, AXTA, BLFY, GDEN Shareholders to Contact the Firm to Discuss Their RightsGlobeNewswire
- BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Repare Therapeutics Inc. (Nasdaq – RPTX), Axalta Coating Systems Ltd. (NYSE – AXTA), Blue Foundry Bancorp (Nasdaq – BLFY), Golden Entertainment, Inc (Nasdaq - GDEN)GlobeNewswire
- Halper Sadeh LLC Encourages THS, RPTX, AXTA Shareholders to Contact the Firm to Discuss Their RightsPR Newswire
- HAPPY THANKSGIVING AND INVESTOR ALERT: The M&A Class Action Firm Continues to Investigate the Merger - RPTX, AXTA, WTG and SEMRPR Newswire
RPTX
Earnings
- 11/14/25 - Beat
RPTX
Sec Filings
- 12/19/25 - Form DEFA14A
- 12/19/25 - Form 8-K
- 12/15/25 - Form DEFM14A
- RPTX's page on the SEC website